California Nanotechnologies Corp.
CANOF
$0.45
$0.01353.09%
OTC PK
| 02/28/2025 | 11/30/2024 | 08/31/2024 | 05/31/2024 | 02/29/2024 | |
|---|---|---|---|---|---|
| Revenue | 86.51% | 123.06% | 173.95% | 193.00% | 141.49% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 86.51% | 123.06% | 173.95% | 193.00% | 141.49% |
| Cost of Revenue | 63.09% | 86.83% | 163.55% | 169.49% | 156.89% |
| Gross Profit | 96.59% | 138.80% | 178.15% | 204.47% | 135.45% |
| SG&A Expenses | 69.04% | 108.54% | 148.66% | 151.13% | 135.47% |
| Depreciation & Amortization | 297.53% | 191.03% | 112.71% | 56.51% | 2.18% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 79.21% | 105.84% | 150.78% | 148.09% | 126.56% |
| Operating Income | 117.54% | 178.73% | 260.18% | 527.53% | 235.60% |
| Income Before Tax | -97.25% | -129.97% | -44.26% | 1,409.42% | 355.61% |
| Income Tax Expenses | -- | -102.44% | -116.67% | -120.00% | -100.00% |
| Earnings from Continuing Operations | -141.50% | -130.13% | -43.15% | 1,503.38% | 378.32% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -141.50% | -130.13% | -43.15% | 1,503.38% | 378.32% |
| EBIT | 117.54% | 178.73% | 260.18% | 527.53% | 235.60% |
| EBITDA | 111.75% | 153.05% | 212.29% | 350.99% | 147.86% |
| EPS Basic | -123.08% | -124.24% | -21.05% | 1,345.00% | 472.00% |
| Normalized Basic EPS | -100.00% | -125.52% | -27.87% | 1,185.71% | 423.53% |
| EPS Diluted | -212.05% | -167.84% | -141.76% | 760.00% | 336.84% |
| Normalized Diluted EPS | -95.06% | -124.09% | -24.14% | 1,169.23% | 406.25% |
| Average Basic Shares Outstanding | 29.35% | 36.63% | 28.49% | 18.69% | 8.95% |
| Average Diluted Shares Outstanding | 36.17% | 43.64% | 34.20% | 21.46% | 11.60% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |